Day: March 19, 2024

HighlightsA 172% increase of Indicated Mineral Resources to 66.1 million tonnes (Mt) containing 1,093 million pounds (Mlb) copper at 0.75%, 678Mlb nickel at 0.47%, 79Mlb cobalt at 0.05%, 2.34 million ounces (Moz) palladium at 1.10 g/t and 0.42Moz platinum at 0.19 g/t; 80% of the Indicated Mineral Resources is Open Pit with 52.7Mt at 0.65% Cu, 0.43% Ni, 0.05% Co, 0.97g/t Pd and 0.17% Pt; Inferred Mineral Resources of 25.9Mt containing 558Mlb copper at 0.98%, 333Mlb nickel at 0.58%, 40Mlb cobalt at 0.07%, 1.12Moz palladium at 1.43 g/t and 0.21Moz platinum at 0.25 g/t; Successful major upgrade of Mineral Resource tonnages from Inferred to Indicated category combined with continued expansion of overall Mineral Resource size along strike and down / up dip; Potential for continued Mineral Resource expansion along strike and at depth over...

Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash., March 19, 2024 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has received Pre-Investigational New Drug (Pre-IND) feedback from the U.S. Food and Drug Administration (FDA) regarding CC-42344 as a potential oral treatment for pandemic and seasonal influenza A. A Pre-IND review provides the opportunity to obtain FDA guidance and clarification on critical steps such as the proposed clinical trial design, as well as clinical drug manufacturing and nonclinical studies deemed necessary before filing the trial design. The feedback was provided in a written response to a Pre-IND package and questions submitted by the Company in January 2024. “We value the FDA guidance as we prepare...

ROCKVILLE, Md., March 19, 2024 (GLOBE NEWSWIRE) — Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it plans to host a conference call on Monday, March 25, 2024, at 8:30 a.m. ET to discuss its financial results for the full year ended December 31, 2023 and provide a corporate update. Individuals may participate in the live call via telephone by dialing 1-877-451-6152 (domestic) or 1-201-389-0879 (international) and using the conference ID: 13744453. Participants are asked to dial-in 15 minutes before the start of the call to register. Investors and the public can access the live and archived webcast of this call via the “News & Media” section of the company’s website, https://www.therivabio.com,...

A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced that it has been granted divisional patent approval by the China National Intellectual Property Administration. The divisional patent approval, previously announced, grants Clearmind a broader claim than patent application. Allowed claims directed to using a primary amine aminoindan compound to regulate a binge behavior. Covers primary amine aminoindan compounds besides 5-methoxy-2-aminoindan (MEAI), the company’s innovative...

Reference is made to the Extraordinary General Meeting in Ensurge Micropower ASA (the “Company”), held today, whereby all proposed resolutions were approved.  Key information relating to the approved share consolidation: Date on which the terms and conditions of the share consolidation was made public: 19 March 2024; Share consolidation ratio: 5 old shares give 1 new share; Last day including right: 4 April 2024;  Ex-date: 5 April 2024; Record date: 8 April 2024; Date of approval: 19 March 2024.  In connection with the share consolidation, the Company’s shares will be transferred to a new ISIN. Please find below the key information for the change of ISIN: Issuer: Ensurge Micropower ASA Old ISIN: NO0012450008 New ISIN: NO0013186460 Date of ISIN change: 5 April 2024 This information is published in accordance with the requirements...

VANCOUVER, British Columbia, March 19, 2024 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) today announces a non-brokered structured private placement offering (the “Offering”), consisting of the issuance of the following securities:up to 1,406,250 CMETC Flow-Through Units (the “CMETC FT Units”) at a price of $0.64 per CMETC FT Unit, to raise gross proceeds of up to $900,000, each CMETC FT Unit consisting of one (1) flow-through common share (“FT Share”) of the Company and one half (1/2) of one transferable non-flow-through common share purchase warrant (each whole common share purchase warrant, a “Warrant”).up to 2,593,750 Flow-Through Units (the “FT Units,” together with the CMETC FT Units, “Offered Securities”) at a price of $0.56 per FT Unit, to raise gross proceeds of up to $1,452,500, each...

Notice is hereby given of the Annual General Meeting of Copenhagen Airports A/S to be held on Tuesday, 16 April 2024 at 3:00 pm. The notice, including the agenda and the full text of the proposed resolutions is attached.COPENHAGEN AIRPORTS A/S P.O. Box 74 Lufthavnsboulevarden 6 DK-2770 KastrupTelephone: +45 32313231 E-mail: cphpresse@cph.dk www.cph.dk CVR no. 14 70 72 04AttachmentCopenhagen Airports A_S – AGM Notice 2024

TORONTO, March 19, 2024 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSX – V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) is pleased to announce Jorge A. Blanco Avilés, a highly experienced metallurgist, has joined its Spanish senior management team as Director of Metallurgy. Mr. Blanco has had a distinguished career as a Metallurgist in both mine site operations and smelting operations, spanning more than 25 years. Since 2010, Mr. Blanco was Metallurgy and Research and Development Manager for First Quantum’s Cobre Las Cruces operation in Andalusia Spain. He successfully spearheaded initiatives to increase copper recovery from 85% to 95% and developed innovative metallurgical processes to recover base metals from Iberian Pyrite Belt polymetallic ores. He also developed and ran an in-house analytical laboratory at...

MONTREAL, March 19, 2024 (GLOBE NEWSWIRE) — Geomega Resources Inc. (“Geomega” or the “Corporation”) (TSX.V: GMA) (OTC: GOMRF), a developer of clean technologies for the mining, refining, and recycling of rare earths and other critical materials, is pleased to provide an update to shareholders on its rare earths recycling demonstration plant, including certain required project design modifications, and an update on site preparation activities that have started at the Saint-Hubert facility. Project engineering updateThe past 6 months have been dedicated to bringing engineering to a sufficient level of completion that it could be tendered to the construction contractors for execution and completion of the rare earths recycling demonstration project. Procurement also progressed and various items were ordered while others were received...